Skip to content

Effect of the SCOT-HEART 2 Trial on Lifestyle.

Effect of the SCOT-HEART 2 Trial on Lifestyle and Risk Factor Modification.

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04156061
Enrollment
400
Registered
2019-11-07
Start date
2020-09-28
Completion date
2027-07-07
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Primary Prevention

Brief summary

This study will recruit 400 participants who are taking part in the Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (SCOT-HEART 2) trial. The investigator will assess diet, activity and habits at the start of the study and 6 months later. This will help us understand the effects taking part in the study may have on lifestyle. In addition, for participants who have CT scans, the investigator will present the results of the heart from the CT scan. This will help us understand how best to explain the results of the CT scan to patients.

Detailed description

This is a sub-study of the SCOT-HEART 2 trial (which aims to determine the best way to prevent heart attacks). The purpose of this sub-study is to determine the effect of getting information on heart disease risk on lifestyle. At present doctors usually use a risk score to identify people at risk of heart disease who may benefit from medical treatment. In the SCOT-HEART 2 study the investigator will compare this risk score to a specialised heart scan (a computed tomography coronary angiogram or CTCA scan). In this study the investigator would like to understand more about the effects of receiving this information about the heart on lifestyle, including effects on smoking, diet and activity. This study will recruit 400 participants who are taking part in the SCOT-HEART 2 trial. The investigator will assess lifestyle by using a detailed questionnaire which will be done at the start of the study and 6 months later. The investigator will also perform some simple investigations including a carbon monoxide breath test, blood pressure tests and measurements of activity such as step counts. This will help us understand the effects on lifestyle of getting information about a risk score or having a CT scan. In addition, for people who have CT scans the investigator will either provide a verbal explanation of the results, as is usual, or show pictures of the heart from the CT scan. This will help us understand how best to explain the results of the CT scan to partipants.

Interventions

OTHERDelivery of CT scan results

Method of results delivery - verbal or visual.

Sponsors

British Heart Foundation
CollaboratorOTHER
NHS Lothian
CollaboratorOTHER_GOV
University of Edinburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* MUST BE ENROLLED IN SCOTHEART 2 TRIAL

Exclusion criteria

* MUST BE ENROLLED IN SCOTHEART 2 TRIAL

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients who meet National Institute for Heath and Care Excellence (NICE) recommendations on risk factor modifications6 monthsThe primary endpoint will be the proportion of patients who meet NICE recommendations on diet, smoking, weight and activity levels (%)

Secondary

MeasureTime frameDescription
Weight loss6 monthsMeasure change in weight via body mass index and waist circumference (%)
Blood pressure control6 monthsChange in blood pressure control through lifestyle/compliance with medications (%)
Lipid levels6 monthsChange in serum lipid levels through lifestyle/compliace with medications (%)
Diabetic control6 monthsChange in glycosylated haemoglobin (HbA1c) (%)
Smoking cessation6 monthsProportion of patients who changed smoking habits (%)
Exercise6 monthsChange in activity levels measured through activity monitoring (step count over 2 weeks) and international physical activity questionnaire
Quality of life/Anxiety and Depression6 monthsChange in quality of life measured through PHQ-9 (patient health questionnaire): anxiety and depression score (%)
ASSIGN score6 monthsChange in ASSIGN score as a result of lifestyle / risk factor modification (%)
Adherence to medications6 monthsChange in compliance with medications tracked through questionnaire

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026